Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma. - Wikidata - wikimedia - TriplyDB

Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.

Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.

http://www.wikidata.org/entity/Q37004657

about

Therapeutic radionuclides in nuclear medicine: current and future prospects Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma.Strategies for the targeted delivery of therapeutics for osteosarcoma.Beyond Palliation: Therapeutic Applications of 153Samarium-EDTMP.Viral vector-based therapeutic cancer vaccines Clinical evaluation of TRICOM vector therapeutic cancer vaccines Palliative therapy for osteosarcoma.Current therapeutic strategies and novel approaches in osteosarcoma.Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.A nuclear chocolate box: the periodic table of nuclear medicine.Targeted molecular radiotherapy of pediatric solid tumors using a radioiodinated alkyl-phospholipid ether analog.Bone sarcomas: from biology to targeted therapies.A treatment planning method for sequentially combining radiopharmaceutical therapy and external radiation therapy.Feasibility study for production and quality control of Yb-175 as a byproduct of no carrier added Lu-177 preparation for radiolabeling of DOTMP.Production and quality control 177Lu (NCA)-DOTMP as a potential agent for bone pain palliation.153Sm: its use in multiple myeloma and report of a clinical experience

P2860

Q26861998-E70177C3-4349-4631-8584-8964ABA0FECD Q33383964-0148F558-FD01-4CC8-A54F-67130BB3DF17 Q34179495-F746A3A2-FF30-497D-8F70-839DB3F69F87 Q35057029-91007149-FF6E-4341-BE26-5BF768445DF9 Q35515080-EF9F071D-9C67-4388-B3EF-2CF49E3ED660 Q36099965-C7077040-3CC2-4C0F-9722-78627AC3F0C9 Q37845831-23EE3922-3ED7-42A0-B779-47BA5DD88982 Q38161735-09A42A57-9FFE-43C6-8BB8-8AD9AA7FC0B4 Q38220804-E8A42E0B-EE2E-4629-BDD7-F1B33A840964 Q38269216-1CBFF6BD-4004-4BF4-9A63-5C384ABA8030 Q38659292-653BA82B-DC21-4151-B8C1-4EC4B355E00C Q41923624-79DC4928-33DD-41AC-9695-AE08CBD9A62E Q42122579-9383448E-D176-4B5D-9306-73101A19547B Q47232721-27568534-5FF1-45D7-9F67-A624F100B944 Q52784096-0AD21F7A-EA6E-425E-8FD5-B1BEFA69CFB6 Q58449064-D4A16E78-2F7A-4929-894E-C7FF7337BDCA

P2860

Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.

http://www.wikidata.org/entity/Q37004657

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Samarium lexidronam (153Sm-EDT ...... e metastases and osteosarcoma.

@en

Samarium lexidronam

@nl

type

label

Samarium lexidronam (153Sm-EDT ...... e metastases and osteosarcoma.

@en

Samarium lexidronam

@nl

prefLabel

Samarium lexidronam (153Sm-EDT ...... e metastases and osteosarcoma.

@en

Samarium lexidronam

@nl

P1433

Q37004657-FC5A3AD0-F1FB-4295-A54E-76D88DEE862C

P1476

Q37004657-BF6CD645-F47D-46C5-9F48-D409AE64C5CE

P2093

Q37004657-8BE3FC59-5F92-4A93-950A-100F05CC685F

Q37004657-A616D1A0-DD81-42EE-88CB-AC9BF5373CD6

P2860

Q37004657-0955C80C-34E2-4BE7-B48A-9B471C243227

Q37004657-0C0EC7F3-DB71-4CA7-8006-3A21146740BD

Q37004657-0C9225CB-0203-4FC1-90D2-01A05261E5C6

Q37004657-0D6DE91A-AAE7-4438-96AB-41214338673C

Q37004657-10E1D489-DA9D-4CCC-B264-5FB14697BBDF

Q37004657-11CC41CE-4AC4-4C9C-B032-3D2EF418F1D0

Q37004657-14EB73B8-6E0C-4BA0-8B89-FD44B55C13F0

Q37004657-17613623-4413-458F-847A-CF46A3F316D1

Q37004657-229D2292-F155-49C1-AD9B-FE7B0FA13109

Q37004657-22D302DA-4A10-43FB-84AB-9C7FEC8A180C

P304

Q37004657-5CAD390D-0F68-46D3-AB2B-A11FFED5EE25

P31

Q37004657-706265BF-BB98-4532-9D5A-2864F1989FC3

P356

Q37004657-C083BE28-BD20-4989-9ECA-837EF790419E

P433

Q37004657-535AE1E5-CA6D-4A48-B42D-9B827435EE1D

P478

Q37004657-2784C271-E3C0-475C-83B2-0D402E2F16C6

P577

Q37004657-6D2CCEB3-2C4D-413B-8F79-61DE586B8B33

P5875

Q37004657-12B77D63-56A6-412F-96EC-64B88B2FE7FA

P698

Q37004657-A3A42FE6-8477-4B45-A74A-1C6508AB95BB

P356

14737140.7.11.1517

P1433

Expert Review of Anticancer Therapy

P1476

Samarium lexidronam (153Sm-EDT ...... e metastases and osteosarcoma.

@en

P2093

Pete Anderson

http://www.w3.org/2001/XMLSchema#string

Rodolfo Nuñez

http://www.w3.org/2001/XMLSchema#string

P2860

Samarium for osteoblastic bone metastases and osteosarcoma

Radioisotopes for the palliation of metastatic bone cancer: a systematic review

Anticancer activities of histone deacetylase inhibitors

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial.

Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem.

High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.

The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain.

Systemic radionuclide therapy in pain palliation.

Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain.

A phase II study of treatment of painful multifocal skeletal metastases with single and repeated dose samarium-153 ethylenediaminetetramethylene phosphonate.

P304

1517-1527

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.7.11.1517

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5826007

http://www.w3.org/2001/XMLSchema#string

P698

18020921

http://www.w3.org/2001/XMLSchema#string